Navigation Links
NYU Langone internist calls for VA system reform
Date:6/10/2014

An NYU Langone internal medicine specialist who served as a White House fellow at the US Department of Veteran's Affairs says the headline-grabbing failures of the VA health system's administration stand in sharp contrast to the highly rated care the system delivers.

In an editorial in The New England Journal of Medicine online June 5, Dave Chokshi, MD, MS, an assistant professor at NYU Langone Medical Center, says the paradox has created a watershed moment to reform and refocus the way the entire system is structured, staffed, and managed, while also building on its clinical excellence.

"With so much public attention focused on the VA's mandate to provide medical care, the time is right to broaden the discussion from access and correcting gaps in the system to actively thinking about how do we design a better VA system that best serves our nation's veterans' medical needs," says Dr. Chokshi.

In the commentary, Chokshi writes that persistent and systemic care-access problems, with long wait times for appointments and scheduling scams, contrast sharply with the documented experience of most veterans who, once in the hands of caregivers, achieve above-average health outcomes and receive high-quality clinical care backed up by laudable patient-satisfaction surveys and scores comparable to private health facilities.

Dr. Chokshi suggests key reforms he says will build on the VA's historic inpatient strengths, including:

  • changing the culture of the VA health care system with respect to communications, expectations, and accountability;

  • creating new scheduling systems and rapid-response teams to deal with backlogs or surges in demand;

  • hiring more primary care physicians to supply basic medical needs to the more than 1 million additional veterans enrolled in VA health care services since 2005;

  • funding increased primary care using the $9 billion already designated for primary care in the 2015 federal budget;

  • attracting clinicians to practice in VA medical centers by establishing cooperative agreements with academic medical centers, where many skilled professionals already have a patriotic desire to help veterans in some meaningful, albeit part-time, way;

  • establishing performance measures for access to, as well as delivery and cost of health services, and using the data to compare them with other medical facilities;

  • renewing VA medical leadership by giving the secretary of the department more latitude in dismissing current executives who fail to meet performance measures that serve veterans' best interests (note: a bipartisan senate bill doing just that was announced last week.)

Dr. Chokshi says he was motivated to weigh into the current debate because the VA responded well to a previous "crisis of confidence" in the 1990s by transforming itself into a quality system for clinical care and averting threats of privatization. "Now it needs to protect the best elements of its infrastructure, build aroundholistic care of each veteran, while embarking on another round of reforms," he adds.


'/>"/>

Contact: David March
david.march@nyumc.org
212-404-3528
NYU Langone Medical Center / New York University School of Medicine
Source:Eurekalert

Related medicine news :

1. Bcureful® Helps Fund Promising Tuberous Sclerosis Complex Research Project at NYU Langone Medical Center
2. NYU and NYU Langone researchers devise method for enhancing CEST MRI
3. NYU Langone Medical Center receives $17 million gift from the Steven A. and Alexandra M. Cohen Foundation
4. NYU Langone experts present research, clinical advances at neurosurgeons meeting
5. Internists recognize todays rotten anniversary
6. Internists review progress, challenges and opportunities
7. Internists respond to SFC with ideas on how to make improvements following repeal of SGR
8. Internists issue 2-pronged plan to improve health care system
9. Internists offer recommendations for solutions to medicare payment problems
10. Internists praise primary care practices inclusion in CPCI
11. Internists recommend principles on role of governments in regulating patient-physician relationship
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... ... The Patient Advocacy Community of The Beryl Institute presented Eve DeVaro, Director, Patient ... Award in recognition of her extraordinary contributions to the field of patient advocacy ... Institute’s annual Patient Experience Conference on March 20 in Denver, Colorado. ...
(Date:4/21/2017)... Hong Kong (PRWEB) , ... April 21, 2017 , ... ... Printing (U3DP), the first 3D printing facility among higher education institutions in Hong Kong ... 3D printing, in terms of the range and quantity of facilities in Hong Kong. ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... AWARE: A Week of Addiction and Recovery Education, from April 24 to April ... preventing substance use disorders. , The mission of AWARE is to instill ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... announced an exciting new partnership with the highly regarded and well renowned Asian ... highly innovative, myTAP & myTAP PAP Nasal Pillow Mask, and will stabilize and ...
(Date:4/21/2017)... Worcestershire, UK (PRWEB) , ... April 21, 2017 ... ... Award for Enterprise in the category of International Trade, the UK’s most prestigious ... in international trade, which represents 95% of total revenues and has grown by ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 Research and ... Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through ... their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production ... an in-depth assessment of the current trends in the ...
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., ... specialty drug prescribing process, today announced it closed $25 million ... a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included participation ... round in 2014, and GV (formerly Google Ventures). ...
(Date:4/20/2017)... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: ... preclinical results demonstrating anti-fibrotic effects with NV556, ... (NASH), in an additional well-validated experimental NASH ... previously shown similar anti-fibrotic effects in the ... present novel data demonstrating anti-fibrotic effects of ...
Breaking Medicine Technology: